Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Schreiber, Rudy (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Cham Springer Nature Switzerland 2024
Cham Springer
Ausgabe:2nd ed. 2024
Schlagworte:
Online-Zugang:URL des Erstveröffentlichers
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zc 4500
001 BV050117594
003 DE-604
007 cr|uuu---uuuuu
008 250113s2024 xx o|||| 00||| eng d
020 |a 9783031619922  |c Online  |9 978-3-031-61992-2 
024 7 |a 10.1007/978-3-031-61992-2  |2 doi 
035 |a (ZDB-2-SME)9783031619922 
035 |a (DE-599)BVBBV050117594 
040 |a DE-604  |b ger  |e rda 
041 0 |a eng 
049 |a DE-578 
082 0 |a 612.8  |2 23 
084 |a MED 000  |2 stub 
245 1 0 |a Modern CNS Drug Discovery  |b Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval  |c edited by Rudy Schreiber 
250 |a 2nd ed. 2024 
264 1 |a Cham  |b Springer Nature Switzerland  |c 2024 
264 1 |a Cham  |b Springer 
300 |a 1 Online-Ressource (XIX, 445 p. 80 illus., 63 illus. in color) 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
650 4 |a Neuroscience 
650 4 |a Pharmaceutics 
650 4 |a Drug Safety and Pharmacovigilance 
650 4 |a Neurosciences 
650 4 |a Pharmaceutical chemistry 
650 4 |a Pharmacovigilance 
700 1 |a Schreiber, Rudy  |4 edt 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |z 978-3-031-61991-5 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |z 978-3-031-61993-9 
856 4 0 |u https://doi.org/10.1007/978-3-031-61992-2  |x Verlag  |z URL des Erstveröffentlichers  |3 Volltext 
912 |a ZDB-2-SME 
940 1 |q ZDB-2-SME_2024 
943 1 |a oai:aleph.bib-bvb.de:BVB01-035454501 

Datensatz im Suchindex

_version_ 1822411961593233408
adam_text
any_adam_object
author2 Schreiber, Rudy
author2_role edt
author2_variant r s rs
author_facet Schreiber, Rudy
building Verbundindex
bvnumber BV050117594
classification_tum MED 000
collection ZDB-2-SME
ctrlnum (ZDB-2-SME)9783031619922
(DE-599)BVBBV050117594
dewey-full 612.8
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 612 - Human physiology
dewey-raw 612.8
dewey-search 612.8
dewey-sort 3612.8
dewey-tens 610 - Medicine and health
discipline Medizin
doi_str_mv 10.1007/978-3-031-61992-2
edition 2nd ed. 2024
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV050117594</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">250113s2024 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031619922</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-031-61992-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-61992-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)9783031619922</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV050117594</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">612.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modern CNS Drug Discovery</subfield><subfield code="b">Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval</subfield><subfield code="c">edited by Rudy Schreiber</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed. 2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer Nature Switzerland</subfield><subfield code="c">2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIX, 445 p. 80 illus., 63 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuroscience</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Safety and Pharmacovigilance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacovigilance</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schreiber, Rudy</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-031-61991-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-031-61993-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-031-61992-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2024</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035454501</subfield></datafield></record></collection>
id DE-604.BV050117594
illustrated Not Illustrated
indexdate 2025-01-27T14:18:01Z
institution BVB
isbn 9783031619922
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-035454501
open_access_boolean
owner DE-578
owner_facet DE-578
physical 1 Online-Ressource (XIX, 445 p. 80 illus., 63 illus. in color)
psigel ZDB-2-SME
ZDB-2-SME_2024
publishDate 2024
publishDateSearch 2024
publishDateSort 2024
publisher Springer Nature Switzerland
Springer
record_format marc
spelling Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval edited by Rudy Schreiber
2nd ed. 2024
Cham Springer Nature Switzerland 2024
Cham Springer
1 Online-Ressource (XIX, 445 p. 80 illus., 63 illus. in color)
txt rdacontent
c rdamedia
cr rdacarrier
Neuroscience
Pharmaceutics
Drug Safety and Pharmacovigilance
Neurosciences
Pharmaceutical chemistry
Pharmacovigilance
Schreiber, Rudy edt
Erscheint auch als Druck-Ausgabe 978-3-031-61991-5
Erscheint auch als Druck-Ausgabe 978-3-031-61993-9
https://doi.org/10.1007/978-3-031-61992-2 Verlag URL des Erstveröffentlichers Volltext
spellingShingle Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
Neuroscience
Pharmaceutics
Drug Safety and Pharmacovigilance
Neurosciences
Pharmaceutical chemistry
Pharmacovigilance
title Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
title_auth Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
title_exact_search Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
title_full Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval edited by Rudy Schreiber
title_fullStr Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval edited by Rudy Schreiber
title_full_unstemmed Modern CNS Drug Discovery Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval edited by Rudy Schreiber
title_short Modern CNS Drug Discovery
title_sort modern cns drug discovery novel therapeutics for psychiatric and neurological diseases from target identification to regulatory approval
title_sub Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
topic Neuroscience
Pharmaceutics
Drug Safety and Pharmacovigilance
Neurosciences
Pharmaceutical chemistry
Pharmacovigilance
topic_facet Neuroscience
Pharmaceutics
Drug Safety and Pharmacovigilance
Neurosciences
Pharmaceutical chemistry
Pharmacovigilance
url https://doi.org/10.1007/978-3-031-61992-2
work_keys_str_mv AT schreiberrudy moderncnsdrugdiscoverynoveltherapeuticsforpsychiatricandneurologicaldiseasesfromtargetidentificationtoregulatoryapproval